Global real-world data can accelerate trials or quietly distort forecasts, inventory strategy, and regulatory decisions across clinical supply operations.
- How AI Can Solve Poor Communication Across Clinical Trial Supply Chains
- Invisible Yet Accountable: How Clinical Supply Pressures Build Strategic Leaders
- From Invisible to Integral: Inviting Clinical Supply Expertise to the Planning Table
- Managing Supply Disruptions In ATIMP Clinical Trials
- What Really Happens During A Temperature Excursion
- Want Faster FDA Release For Pharmaceutical Imports? Here's How.
- Decision Authority And Direction — The Gap In Deviation Planning
- Achieving Forecasting And Inventory Agility In A Volatile Clinical Trial Supply Environment
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
Automation Testing In RTSM Software: What Is It And What's The Impact
Move beyond the limitations of manual oversight to see how automated frameworks ensure precision, speed, and reliability for the most sophisticated and adaptive clinical trial designs.
-
Unblinding Risks In RTSM: What's Still Going Wrong, And How Korio Fixes It
Protecting study integrity requires more than just luck. Learn how systemic gaps lead to unintentional unblinding and how a proactive, engine-based approach can safeguard your clinical data.
-
How CDMOs Deliver Precision and Scale in Pharma Spray Drying
Spray drying depends on precise control, scalable methods, and solid quality systems. Strong design and GMP‑aligned execution help reduce risk and move complex compounds forward efficiently.
-
IRT? RTSM? What's The Difference?
What are the components of Randomization and Trial Supply Management (RTSM) and the critical role of RTSM and Interactive Response Technology (IRT) in clinical trials?
-
Optimizing IRT For Clinical Supply Management
Experts speak on supply capabilities within interactive response technology (IRT) – how flexibility is important to functionality and who to involve and which questions to ask in optimizing IRT for clinical supply.
-
Bringing A Biosimilar For Oncology To Market: Injectable Packaging From Early Development To Commercialization
While in their early-stage development of a mAb biosimilar for oncology treatment, a large biopharmaceuticals company sought a packaging recommendation: a stopper to maintain high-quality standards.
-
Modern Architecture's Impact On UX In Next-Gen Interactive Response Tech
Explore how Interactive Response Technologies (IRTs) built around microservices models can provide faster initial builds, more rapid change management, and improved built-in test automation.
-
Navigating The Biopharma Finance And Accounting Tech Landscape
During clinical trials, the intricacies of financial management intensify, necessitating advanced ERP functionalities to handle clinical accruals, compliance, and reporting.
-
Key Considerations For Labeling Your Cell Or Gene Therapy
As sponsors focus on maintaining the temperature range required for cell and gene therapies, they must also keep in mind the challenges this task presents when properly labeling them for clinical trial distribution.
-
How Are You Labeling Your IP? Protect Your Clinical Trial With Distinct Treatment Numbers
Explore why engaging randomization and trial supply management (RTSM) services early in study startup can help protect clinical trials and expose substantial efficiencies, effectively baking in practices that help streamline supply chains.
CATALENT CORNER
| Insights from Catalent's Clinical Supply Experts |
SPONSORED CONTENT
Impact Of Supplier Choice On APAC Clinical Trial Execution
Learn about strategies Asia-Pacific has become an increasingly complex and congested destination for clinical trials as local and global sponsors alike flock to the region to take advantage of its many benefits, including access to large patient pools. Choosing the right clinical packaging and supply chain partner to support these studies is critical and can vary significantly based upon what countries are involved and the types of services required.